Nkarta (NKTX) Cash & Equivalents (2019 - 2026)
Nkarta (NKTX) recorded quarterly Cash & Equivalents of $266.7 million in Q1 2026, up 572.91% quarter-over-quarter from $39.6 million in Q4 2025, and up 407.05% on a YoY basis from $52.6 million in Q1 2025.
Nkarta (NKTX) Cash & Equivalents (2019 - 2026) Analysis & Trends
Nkarta's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $266.7 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 407.05% year-over-year to $266.7 million; the TTM figure through Mar 2026 stood at $266.7 million (up 407.05% YoY), while the FY2025 annual figure was $39.6 million, up 42.19% from the prior year.
- Cash & Equivalents was $266.7 million for Q1 2026 at Nkarta, up from $39.6 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $334.0 million in Q2 2025 to a low of $27.9 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $94.8 million across 5 years, with a median of $52.6 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 439.07% in 2022, then tumbled 78.98% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $37.5 million in 2022, then slipped by 17.21% to $31.0 million in 2023, then fell by 10.2% to $27.9 million in 2024, then jumped by 42.19% to $39.6 million in 2025, then surged by 572.91% to $266.7 million in 2026.
- The last three Cash & Equivalents figures came in at $266.7 million (Q1 2026), $39.6 million (Q4 2025), and $60.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 558.94 Mn |
| 10 | Nkarta | 210.15 Mn | 210.15 Mn | - | 266.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.70 Mn |
| Dec 31, 2025 | 39.63 Mn |
| Sep 30, 2025 | 60.11 Mn |
| Jun 30, 2025 | 334.00 Mn |
| Mar 31, 2025 | 52.60 Mn |
| Dec 31, 2024 | 27.87 Mn |
| Sep 30, 2024 | 56.96 Mn |
| Jun 30, 2024 | 120.40 Mn |
| Mar 31, 2024 | 250.29 Mn |
| Dec 31, 2023 | 31.04 Mn |
| Sep 30, 2023 | 38.26 Mn |
| Jun 30, 2023 | 29.12 Mn |
| Mar 31, 2023 | 53.67 Mn |
| Dec 31, 2022 | 37.49 Mn |
| Sep 30, 2022 | 39.65 Mn |
| Jun 30, 2022 | 131.65 Mn |
| Mar 31, 2022 | 41.61 Mn |
| Dec 31, 2021 | 60.82 Mn |
| Sep 30, 2021 | 96.22 Mn |
| Jun 30, 2021 | 24.42 Mn |